The purpose of this study is to look at the effectiveness of two chemo regimens mFOLFOX6 or CAPOX vs mFOLFIRINOX in getting patients to remission. You must be diagnosed with stage 2 or 3 rectal cancer.
Contact phoneTera Williams | 517.364.2910
Principal investigatorDr. Gordan Srkalovic, MD, PhD